Overview

Natural Killer Cells in Older Patients With Acute Myeloid Leukemia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Studying natural killer cells in samples of blood from patients with cancer may help doctors find out how these cells are effected by chemotherapy. PURPOSE: This clinical trial is studying natural killer cells in older patients with acute myeloid leukemia.
Phase:
N/A
Details
Lead Sponsor:
Institut Paoli-Calmettes
Treatments:
Cytarabine